Jointown Pharmaceutical boosts subsidiary guarantees by 223 bn yuan

Jointown Pharmaceutical Group Co., Ltd. has provided an additional 223 billion yuan in guarantees for its 26 subsidiaries, including Shandong Jointown Pharmaceutical Co., Ltd. and Wuhu Jointown Pharmaceutical Sales Co., Ltd. This brings the total actual outstanding guarantees to 1,102.4 billion yuan. These guarantees are primarily for comprehensive credit facilities and other business operations.

The company's total external guarantees as of October 31, 2025, including those for its controlling subsidiaries and their sub-subsidiaries, reached 2,851.75 billion yuan. This represents 104.68% of the company's net assets as of the latest audited period (December 31, 2024). The company confirmed that there are no overdue external guarantees.

The guarantees are considered necessary and reasonable as Jointown maintains control over the guaranteed entities, which are reported to be in good operational standing, thus mitigating associated risks. The board of directors has approved these guarantees, which align with the company's business development and operational needs, and are not expected to negatively impact shareholder interests.